CERENO SCIENTIFIC AB (PUBL) Cereno Scientific AB (publ) Stock NORDIC GROWTH MARKET
Equities
CRNO B
SE0008241558
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.521 SEK | -7.13% |
|
+7.98% | -76.90% |
| Apr. 16 | Cereno Scientific AB Approves Election of New Directors | CI |
| Apr. 11 | Cereno Scientific Secures Patent Expansion in Canada for Hypertension Drug Candidate | MT |
| Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.13B 104M |
|---|---|---|---|---|---|
| Net income 2024 * | -75M -6.89M | Net income 2025 * | -42M -3.86M | EV / Sales 2024 * | - |
| Net Debt 2024 * | 3M 276K | Net Debt 2025 * | 145M 13.35M | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-21.2
x | P/E ratio 2025 * |
-23.7
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.66% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -7.13% |
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 15-08-31 | |
Eva Jagenheim
DFI | Director of Finance/CFO | 58 | 23-08-27 |
Fredrik Frick
CTO | Chief Tech/Sci/R&D Officer | 51 | 22-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 71 | 12-04-11 | |
| Director/Board Member | 47 | 12-04-11 | |
| Founder | 70 | 12-03-31 |
Cereno Scientific AB is a manufacturer of pharmaceutical preparation. The Company was founded in 1970 and is located in Gothenburg, Sweden.
Calendar
2024-05-22
- Q1 2024 Earnings Release
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.26% | 104B | |
| +1.41% | 97.42B | |
| +0.79% | 22.2B | |
| -17.84% | 21.23B | |
| -11.11% | 18.33B | |
| -42.83% | 16.35B | |
| -17.63% | 15.06B | |
| +4.55% | 13.98B | |
| +32.11% | 11.66B |
- Stock Market
- Equities
- CRNO B Stock
- CRNO B Stock
